Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - VALEANT PHARMACEUTICALS INTERNATIONAL | a55998e10vq.htm |
| EX-15.1 - EX-15.1 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55998exv15w1.htm |
| EX-15.2 - EX-15.2 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55998exv15w2.htm |
| EX-31.1 - EX-31.1 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55998exv31w1.htm |
| EX-31.2 - EX-31.2 - VALEANT PHARMACEUTICALS INTERNATIONAL | a55998exv31w2.htm |
Exhibit 32.1
Certification
pursuant to 18 U.S.C. Section 1350,
As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, each of the
undersigned officers of Valeant Pharmaceuticals International
hereby certifies, to the best of such officer’s knowledge,
that:
1. The Registrant’s Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2010 (the
“Report”) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
as amended, and
2. The information contained in the Report fairly presents,
in all material respects, the financial condition and results of
operations of the Registrant as of and for the periods presented
in the Report.
/s/ J. Michael Pearson
J. Michael Pearson
Chairman and Chief Executive Officer
Date: May 3, 2010
/s/ Peter J. Blott
Peter J. Blott
Executive Vice President and Chief Financial Officer
Date: May 3, 2010
A signed original of this written statement required by
Section 906 has been provided to Valeant Pharmaceuticals
International and will be furnished to the Securities and
Exchange Commission or its staff upon request.